Hypertension 
Welcome,         Profile    Billing    Logout  

3816 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hypertension
ACTRN12617001533381p: Combination low dose blood pressure lowering treatment for patients with untreated hypertension

Not yet recruiting
4
12
 
George Medicines, George Medicines (The George Institute)
Hypertension
 
 
ACTRN12617001533381: Combination low dose blood pressure lowering treatment for patients with untreated hypertension

Not yet recruiting
4
12
 
George Medicines, George Medicines (The George Institute)
Hypertension
 
 
ACTRN12606000289516: Pulmonary Artery Remodelling With Bosentan

Not yet recruiting
4
15
 
Actelion Phrmaceuticals Australia, Actelion Phrmaceuticals Australia
Hypertension, Pulmonary
 
 
ACTRN12616001088437p: Does locally produced Enalapril (Envas) work as well as imported Enalapril (EnaDenk) in the treatment of individual patients with hypertension? Addis Ababa, Ethiopia

Not yet recruiting
4
30
 
University of Queensland, University of Queensland
Hypertension
 
 
ACTRN12616001088437: Does locally produced Enalapril (Envas) work as well as imported Enalapril (EnaDenk) in the treatment of individual patients with hypertension? Addis Ababa, Ethiopia

Not yet recruiting
4
30
 
University of Queensland, University of Queensland
Hypertension
 
 
ACTRN12624000883516: Safety of ibuprofen to manage pain after caesarean section for women who have hypertension in pregnancy - a randomised pilot study

Not yet recruiting
4
80
 
Royal North Shore Hospital , Ramsay Healthcare- Ramsay Research and Education Grant
chronic hypertension , Preeclampsia, gestational hypertension
 
 
ACTRN12622000391774p: A Randomised trial assessing Efficacy and safety of Mineralocorticoid receptor Antagonist therapy compared to Standard antihypertensive Therapy in hypErtension with low Renin (REMASTER)

Not yet recruiting
4
100
 
Dr Jun Yang, Dr Jun Yang
Low-renin hypertension
 
 
ACTRN12614000461695: Assessment of the Effects of Cardiopulmonary Phenotype on Oral and intravenous (IV) Frusemide Pharmacokinetics

Recruiting
4
20
 
Flinders University, Flinders University
Congestive Heart Failure, Pulmonary Hypertension
 
 
ACTRN12610001024033: Safety and Benefits of A Tablet Combining Losartan and Hydrochlorothiazide in Hypertensive Patients with Diabetes

Recruiting
4
30
 
Keio University School of Medicine, Keio University School of Medicine
diabetic patients with hypertension
 
 
ACTRN12608000371392: A Randomised Controlled Trial of Medical Prophylaxis for the Prevention of Hypertension, Renal Disease and Diabetes in Australian Aborigines

Recruiting
4
200
 
The University of Queensland, Colonial Foundation Limited, NHMRC- National Health and Medical Research Council
Diabetes, Hypertension, Renal Disease
 
 
ACTRN12609000838213: Olmesartan Clinical Trial in Okinawan Patients Under Okinawa Dialysis Study

Active, not recruiting
4
462
 
Kinitoshi Iseki
chronic hemodialysis patients (3/week), Hypertension
 
 
2016-002991-28`ACTRN12620001349932: The GRASP Trial - "Getting it Right: Addressing Shoulder Pain"

Ongoing
4
704
Europe
Methylprednisolone acetate, Triamcinolone acetonide, Injection, Solution for injection, Depo-Medrone, Kenalog
University of Oxford, NIHR Health Technology Assessment Programme
Pulmonary Hypertension, Right heart failure
 
 
2020-003647-28`ACTRN12620001373965: Blood pressure lowering drug concentration differences in the blood of patients with hypertension: Old vs. Young 2

Ongoing
4
80
Europe
Film-coated tablet, Losartan potassium, Perindopril Arginine
Monash Medical Centre , Monash University Health Practitioner Research Fellowship
The pharmacokinetics of oral creatine monohydrate (CrM) dosing in pregnancy, Metabolism of nutraceutical supplement (creatine monohydrate) in pregnancy
 
 
2021-000880-63`ACTRN12609000047291: COVID-19 vaccine in patients with rheumatic diseases: The impact of treatments on the vaccine response protection against infection (COVID19-REUMA) COVID19 vaccin hos patienter med reumatiska sjukdomar: effekter av behandlingen på vaccinsvar och skydd mot infektion

Ongoing
4
868
Europe
Comirnaty, COVID-19 Vaccine AstraZeneca, COVID-19 Vaccine Moderna, Injection, Comirnaty, COVID-19 Vaccine AstraZeneca, COVID-19 Vaccine Moderna
Skåne University Hospital, department of rheumatology in Lud and Malmö, Skåne University Hospital, Department of rheumatology in Lund and Malmö
Pre-hypertension
 
 
ACTRN12622000391774: A Randomised trial assessing Efficacy and safety of Mineralocorticoid receptor Antagonist therapy compared to Standard antihypertensive Therapy in hypErtension with low Renin (REMASTER)

Recruiting
4
100
 
Dr Jun Yang, Dr Jun Yang
Low-renin hypertension
 
 
ChiCTR-ONC-11001612: Observational investigation in hospital of Songling Xuemaikang Capsule for treating primary hypertension, a real word study

Recruiting
4
5000
 
Songling Xuemaikang Capsule
Dongzhimen Hospital; Dongzhimen Hospital, Pharmaceutical Co., Ltd. Chengdu Nakasone
primary hypertension
 
 
ChiCTR-OCH-12002780: Clinical observation on curative effect of uniting use of Capsules of compound Cortex Moutan & Leech and Aspirin on improving the prethrombotic state in patients with Type 2 diabetes mellitus and hypertension

Completed
4
150
 
Add a Dan vermiculite hypoglycemic capsule ;Add a Dan vermiculite hypoglycemic capsule
Senium Vasculocardiology Deparment, The first affiliated hospital of TCM college of Anhui province; The first affiliated hospital of TCM college of Anhui province, The special topic fund of TCM Science and Technology study of The State Administration of Traditional Chinese Medicine.( 06-07LP22)
Diabetes mellitus AND Cardiovascular disease
 
 
2005-004288-47: Etude des effets d'un antagoniste calcique(la barnidipine) sur la sensibilité des chémorécepteurs et l'activité orthosympathique.

Ongoing
4
24
Europe
Vasexten, Capsule*, Vasexten
Hôpital Erasme
2 groups of patients: one group of patients with systemic hypertension and one another group with control subjects free of disease
 
 
2006-002065-39: Primaarin ja sekundaarisen hypertension hemodynamiikka: DYNAMIC–tutkimus

Ongoing
4
1000
Europe
Sublingual tablet, Inhalation vapour, liquid, Nitro, Ventoline evohaler
Ilkka Pörsti ja tutkimusryhmä
Terveet vaapaaehtoiset Primaari hypertensio Sekundaari hypertensio Munuaisten vajaatoiminta Ateroskleroottinen valtimosairaus
 
 
2006-003133-33: Etude des effets d’un antagoniste non spécifique de l’endothéline (le bosentan) sur l’activité orthosympathique et le chémoréflexe.

Ongoing
4
20
Europe
Tablet, Tracleer
Hôpital Erasme
healthy subjectsobstructive sleep apnea(Bosentan is used in clinic in pulmonary hypertension)
 
 
ChiCTR-TRC-08000251: Percutaneous Transhepatic Variceal Embolization versus Endoscopic Injections with Histoacryl for the treatment of gastric fundus varices: A Randomized Controlled Trial

Completed
4
72
 
Patients has gastroscopy to investigate the degree of gastric fundus varices; Histoacryl blue injection was performed using an Olympus electronic gastroscope and a disposable injection needle. Each shot contained 0.5ml Histoacryl and 0.5ml Lipiodol. Last the needles were rinsed with 5% Glucose. ;The included patients was performed PTVE by venipuncture, intubation tube, visualization, histoacryl was then injected continuously until all the gastric fundus varices and opacified. During withdrawal of the sheath, the needle tract was closed with gelatin sponge or stainless-steel coils.
Shandong Provincial Hospital; Shandong University, Shandong Province Key Scientific and Technological Projects
liver cirrhosis; portal hypertension; gastric fundus varices; alimentary tract hemorrhage
 
 
ChiCTR-TRC-09000538: The study on pathogeny of hypertension and the salt intervention on diet in the population of Zhangwu County

Completed
4
541
 
take salt with lower Natrium ;take common Iodine salt
The First Hospital of China Medical University; Level of the institution:, Science and technology projects of Liaoning Province
Hypertension
 
 
2007-005655-42: STUDY TITLE: - Early Metabolic Changes with Thiazide or Beta blocker Therapy for Essential Hypertension – open label extension phase with the potassium sparing diuretic- Amiloride.

Ongoing
4
60
Europe
Amiloride hydrochloride, Tablet, No trade name (Generic amiloride hydrochloride)
Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital
Essential hypertension
 
 
ChiCTR-TRC-10001071: The Effect of Amlodipine and Valsartan in Hypertensive Renal Post-transplant Patients

Completed
4
150
 
amlodipine(Norvase, 5mg/tablet) + metoprolol(Betaloc,12.5mg/tablet) ;valsartan(Diovan, 80mg/tablet) +metoprolol(Betaloc,12.5mg/tablet)
the Third Xiangya Hospital of Central South University; Hunan Science and Technology Bureau, Science and Technology Program of Hunan (2006SK2003)
Post-transplant hypertension
 
 
CHEAPS, ChiCTR-PRC-06000006: Controling for hypertension as risk factor to prevent stroke with low cost in countryside

Completed
4
6000
 
Health education + treating for antihypertention + treating for decreasing lipid; Health education + treatment for antihypertention; Health education
Shengjing Hospital of China Medical University; The Department of Science and Technique, Liaoning Province Government, The Department of Science and Technique, Liaoning Province Government
stroke
 
 
ChiCTR-TRC-08000242: The mechanisms and effects on organ protection of combination of nitric oxide gas and iloprost during cardiopulmonary bypass

Completed
4
60
 
routine CPB plus NO plus iloprost ;routine CPB plus iloprost ;routine CPB plus NO ;routine CPB not taking any drugs
Department of Thoracic and Cardiovascular Surgery, West China Hospital; The National Natural Science Fundation, The National Natural Science Funds
isolated atrial septal defects and/or ventricular septal defects with/without pulmonary hypertension
 
 
ChiCTR-TNRC-08000263: The study of the intervention with statin on PE and CTEPH

Completed
4
60
 
basic treatment + atorvastatin ;basic treatment
Tongji Hospital of Tongji University; Level of the institution:, the study for Doctor's degree
pulmonary embolism and chronic thromboembolic pulmonary hypertension
 
 
ChiCTR-TRC-09000426: Randomized controlled trial of losartan\propranolol in treating portal hypertension

Completed
4
90
 
Oral losartan by 25mg/d of the initial dose, three days latter alternate to 50mg/d ;Oral propranolol by 20mg/d of initial dose; then, progressively increase 10mg/d, max dose 120mg/d or rest heart rate reduced to the 75% of fundamental rate, or no less than 55/min ;Placebo
Department 1 of Infectious Diseases, 302 Hospital of P.L.A; Level of the institution:, self-finance
portal hypertension
 
 
ChiCTR-TNC-10000898: The pharmacokinetics and pharmcodynamics of telmisartan tablet

Completed
4
60
 
After an overnight fast, the subjects ingested a single 40mg dose of telmisartan with 250ml water
Central South University; Level of the institution:, Self-financing
Hypertension
 
 
CHIEF, ChiCTR-TRC-08000087: Randomised trial of initial low-dose CCB and ARB combination in Chinese hypertension patients (updated in February 5 2009)

Completed
4
24000
 
(Total Cholesterol concentration of participants: <4.0 or >6.1mmol/L). Amlodipine 2.5mg and compound amiloride half of a tablet. ;(Total Cholesterol concentration of participants <4.0 or >6.1mmol/L). Amlodipine 2.5mg and telmisartan 40mg. ;(Total Cholesterol concentration of participants: 4.0-6.1mmol/L). Amlodipine 2.5mg, telmisartan 40mg and simvastatin 10mg. ;(Total Cholesterol concentration of participants: 4.0-6.1mmol/L). Amlodipine 2.5mg and telmisartan 40mg, regular remedy of serum lipid decided by the doctors. ;(Total Cholesterol concentration of participants 4.0-6.1mmol/L). Amlodipine 2.5mg and compound amiloride half of a tabella and regular remedy of serum lipid decided by the doctors. ;(Total Cholesterol concentration of participants: 4.0-6.1mmol/L). Amlodipine 2.5mg, compound amiloride 2.5mg and simvastatin 10mg ;(Includes group 1, group 2, and group 5). Amlodipine 2.5mg, compound amiloride half of a tablet. ;(Includes group 3, group 4 and group 6). Amlodipine 2.5mg, telmisartan 40mg.
Fu Wai Hospital for Cardiovascular Disease; The Ministry of Science and Technology of the People's Republic of China, The Ministry of Science and Technology of the People's Republic of China
Hypertension
 
 
ChiCTR-TRC-08000041: A randomized controlled trial of Selective Decongestive Devascularization Shunt of Gastrosplenic Region and Pericardial Devascularization with Splenectomy in the treatment of portal hypertension

Completed
4
160
 
SDDS-GSR operation ;PCDV operation
No.1 Hospital Affiliated to Wenzhou Medical College; Scientific Foundation of Zhejiang Province and Wenzhou Scientific and Technologic Bureau, Scientific Foundation of Zhejiang Province and Wenzhou Scientific and Technologic Bureau
Portal hypertension due to liver cirrhosis
 
 
ChiCTR-TRC-10001128: Standardized study of integrated traditional Chinese and western medicine on the treatment of senile hypertension

Completed
4
300
 
the control group are given extended release nifedipine tablets 10mg bid and Enalapril Maleate Tablets 10mg bid.and if the participent couln't resist the adverse reaction,change to indapamide tablet 2.5mg qd. ;on the basic medication of the control group ,the treatment group are given different herbal medicine according to the syndrome differentiation
Xiyuan Hospital of Chinese Academy of Medical Science; State Administration of Traditonal Chinese Medicine of The People’s Republic of China, National Key Technology R&D Program of China
senile hypertension
 
 
ChiCTR-TRC-11001653: The research about decompression cure IFG and Hypertension

Completed
4
600
 
Levamlodipine Besylate ;Losartan
Endocrinology department, The Third Military Medical College, Southwest Hospital Chongqing; Endocrinology department, The Third Military Medical College, Southwest Hospital Chongqing, hospital administration funds
IFG and Hypertension
 
 
ChiCTR-OCH-12002611: Genetic polymorphisms affect therapeutic response to angiotensin-converting enzyme inhibitors in Chinese hypertensive patients

Completed
4
1000
 
no ;antihypertensive drug
Institute of Clinical Pharmacology, Central South University; Institute of Clinical Pharmacology, Central South University, Self-financing
Hypertension
 
 
ChiCTR-TRC-10001091: 7-day hemodynamic response to carvedilol combined with isosorbide mononitrate (ISMN) versus carvedilol alone in cirrhotic patients: a randomized controlled trial

Completed
4
100
 
Carvedilol, orally taken for 7 days. The initial dosage is 12.5mg once daily, and the dosage is modulated for the target that the heart rate reduces below 55 per minute or the reduction > 20% of the baseline heart rate. Keep the systolic blood pressure ≥90mmHg. Once hypotension occurs, reduce the dosage at once and drug withdrawl is required if necessary. ;Carvedilol+Isosorbide Mononitrate Sustained Release Tablets, orally taken for 7days. The initial dosage of carvedilol is 12.5mg once daily, and ISMN 30mg daily. The dosage is modulated for the target that the heart rate reduces below 55 per minute or the reduction > 20% of the baseline heart rate. once hypotension occurs, reduce the dosage at once and drug withdrawl is required if necessary.
Shandong Provincial Hospital; Level of the institution:, Self-fianace
portal hypertension
 
 
ChiCTR-PRC-08000217: CHINOM, sub-project of CHIEF, a project of The National 11th Five-year plan, Science-Technology Ministry

Completed
4
4800
 
telmesartan capsule 40mg/day ;Beijing 0 tablets 0.5#/qd ;placebo tablets 0.5#/qd ;Indapamide 1.5mg/capsule, once two days
Beijing Double-Crane Pharmaceutical Co., Ltd.; Ministry of Science and Technology of The People's Republic of China, 11th National Five-Year Plan + Sponsorship
Hypertension, Cardiovascular diseases
 
 
2011-005545-12: ENCHANTED: A Trial to assess the effects of low- vs standard-dose clot-busting and intensive vs standard blood pressure-lowering treatments on outcome after acute ischaemic stroke

Ongoing
4
5000
Europe
Actilyse, Labetalol, Glyceryl trinitrate, Glyceryl Trinitrate, Powder and solvent for solution for infusion, Powder and solvent for solution for injection/infusion, Solution for injection, Transdermal patch, Solution for infusion, Actilyse, Labetalol
University of Leicester, National Health and Medical Research Council
Acute Ischaemic Stroke, Stroke or 'Brain Attack' caused by a clot., Diseases [C] - Nervous System Diseases [C10]
 
 
ChiCTR-TRC-11001663: Administration time-dependent effects of aspirin on blood pressure variance and morning blood pressure peak of nonhypertension patients with coronary heart disease

Completed
4
30
 
Besides the basic treatment aspirin on awakening for 2weeks and then taking aspirin at bedtime for 2 weeks ;aspirin at bedtime for 2weeks,and then taking aspirin on awakening for 2weeks.
The Second Hospital of Hebei Medical University; The Second Hospital of Hebei Medical University, Department of Cardiology
coronary heart disease
 
 
ChiCTR-ECS-11001793: The practice of glucose management in cardiovascular department

Completed
4
4100
 
acarbose
The General Hospital of the People's Liberation Army (PLAGH); The General Hospital of the People's Liberation Army (PLAGH), Bayer healthcare
Hypertension and ischemic heart disease
 
 
ChiCTR-OCH-12002710: Pharmacogenetics study of hydrochlorothiazide and felodipine in Chinese hypertensive patients

Completed
4
1325
 
Hydrochlorothiazide ;Hydrochlorothiazide+Felodipine
Institute of Clinical Pharmacology, Central South University; Institute of Clinical Pharmacology, Central South University, 863 project
Hypertension
 
 
ChiCTR-TRC-08000320: Fixed-dose Combination for Antihypertensive Therapy in the Community Healthcare

Completed
4
750
 
FUFANGJIANGYAPIAN 1 TABLET, 1 TABLET TID PO ;FUFANGJIANGYAPIAN 1 TABLET, 1 TABLET TID PO
Fuwai Hospital; Beijing ShuangHe pharmaceutical company, Enterprise funded
hypertension
 
 
ChiCTR-PRNC-12002690: Effects of CACNA1C, eNOS, and RGS2 gene polymorphisms on the antihypertensive response of dihydropyridine calcium channel blockers in patients with essential hypertension.

Completed
4
70
 
antihypertension drugs
Institute of Clinical Pharmacology in Central South Univiersity; Institute of Clinical Pharmacology in Central South Univiersity, the "863" Project (No. 2012AA02A518)
essential hypertension
 
 
ChiCTR-RCH-12002864: Relationship between genetic polymorphisms and adverse reaction of antihypertensive drugs in patients with essential hypertension

Completed
4
1600
 
no ;antihypertensive drugs
Institute of Clinical Pharmacology, Central South University; 湖南长沙市湘雅路110号中南大学临床药理研究所, 863 project
Hypertension
 
 
ChiCTR-TRC-10001142: Early intervention with supplemental of vitamin D in patients with primary hypertension and vitamin D deficiency

Completed
4
200
 
Calcium (600mg/d)+vitamin D (800IU/d) ;Calcium (1200mg/d)+vitamin D (400IU/d) ;Calcium (600mg/d)+vitamin D (400IU/d) ;Calcium (1200mg/d)+vitamin D (800IU/d)
The first hospital affiliated to Xinjiang Medical University; The first hospital affiliated to Xinjiang Medical University, Evidence-based medicine special fund of the first hospital affiliated to Xinjiang Medical University
primary hypertension
 
 
ChiCTR-ONC-11001799: A single center, open lable clinical study of bosentan therapy in pediatric patients with severe pulmonary arterial hypertension due to congenital heart disease

Completed
4
50
 
Bosentan therapy
Beijing Anzhen Hospital; Beijing Anzhen Hospital, Actelion Pharmaceuticals Ltd
pediatric patients with severe pulmonary arterial hypertension due to congenital heart disease
 
 
ChiCTR-ONC-11001645: Nitrendipine/atenolol combination tablets anti-hypertension treatment in community healthcare

Completed
4
9000
 
The enrolled patients aged 18-70 will be treated with nitrendipine/atenolol combination tablets for 6 months(some of them will be treated for 12 months). The initial dose comprised two tablets of nitrendipine(5 mg)/atenolol(10 mg) between 8:00 am and 10:00 am once a day.; If the blood pressure is higher than that of baseline at the end of the second week, the drugs may increase to 3 tablets(taking an additional tablet of drug at about 18:00 pm). If the blood pressure are poor controlled (≥ 140/90 mmHg) at the end of the fourth week, the drugs taken in the afternoon may increase to 2 tablets.; If the blood pressure are poor controlled (≥ 140/90 mmHg) at the end of the second month, the patients may take other antihypertensive drugs (other CCB and β-blockers are not allowed to take). If dose-related intolerance symptoms, suspected or definite low blood pressure occur in patients,the drugs taken may be reduced gradually.
The Beijing Hypertension League Institute; Fuwai Hospital PUMC & CAMS, Jiangsu Jiberer Pharmaceutical Company Limited
Primary hypertension
 
 
ChiCTR-TRC-13003424: The effect of long-acting octreotide on portal hypertension

Completed
4
45
 
0.9%saline muscular injection monthly ;20mg long-acting octreotide muscular injection mon ;40mg long-acting octreotide muscular injection mon
Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital, none
portal hypertension
 
 
ChiCTR-ONC-12001963: Olmesartan Medoxomil Oracle Clinical Trial

Completed
4
400
 
All eligible subjects will receive OLM 20mg/d additionally on the treatment of AML 5mg/d to lower the blood pressure at least for 8 weeks. If target blood pressure (SeDBP<90mmHg, SeDBP<80mmHg for DM subjects) is not achieved, up titrate to OLM 40mg/d with AML 5mg/d or add HCTZ 12.5mg/d on OLM 20mg/d (fixed combination tablet of OLM/HCTZ) and AML 5mg/d according to the judgment of investigators.
Ruijin Hospital Affiliated to The Shanghai Jiao Tong University Medical School; Daiichi Sankyo Pharmaceutical (Shangjhai) Co., LTD., Daiichi Sankyo Corporation
Hypertension
 
 
2013-002000-14: De effecten van een rechter paravertebraal blok op de werking van het hart bij patiënten met pulmonale hypertentie die minimaal invasieve mitralisklepchirugie ondergaan.

Ongoing
4
50
Europe
Chirocaine, Solution for injection, Chirocaine
University Hospitals Leuven, University Hospitals Leuven
patients with pulmonary hypertension scheduled for elective minimally invasive mitral valve surgery using heartport technique., patients with pulmonary hypertension scheduled for elective minimally invasive mitral valve surgery using heartport technique., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
ChiCTR-OCH-12002769: Pharmacogenomics study of telmisartan and indapamide in patients with essential hypertension

Completed
4
1800
 
telmisartan ;ndapamide
Institute of Clinical Pharmacology, Central South University; Institute of Clinical Pharmacology, Central South University, 863 project
Hypertension
 
 
ChiCTR-ONC-12002826: Perioperative Use of Inhaled and Intravenous Iloprost in Patients with Pulmonary Hypertension during Non-cardiac Surgery

Completed
4
30
 
Iloprost Inhalation
Beijing Shijitan Hospital, Capital Medical University; Beijing Shijitan Hospital, Capital Medical University, Self-financing
Patients with Pulmonary Hypertension
 
 
ChiCTR-TRC-11001781: A multi-centre study of urapidil versus nitroglycerin in the treatment of AHF patients with hypertension

Completed
4
300
 
Urapidil injection titrated to target dose within 6 hours. Treatment lasts for 48 hours.
Department of Cardiology, Xuanwu Hospital, Capital Medical University; China International Medical Communicational Foundation, Funds obtained from collaboration project
Acute Heart Failure with hypertension
 
 
ChiCTR-TRC-12001910: An investigation for blood 25 (OH) D concentration and intervention study in hypertension population with low serum 25 (OH) D concentration in Urumqi

Completed
4
400
 
Calcium antagonists and Calcitriol capsule treatme ;Calcium antagonists and Calcitriol placebo capsule treatme
The First Affiliated Hospital of Xinjiang Medical University; Urumqi Science and Technique Committee, science and technology plan projects special fund in Urumqi
Hypertension
 
 
2014-000605-12: Comparison of two drugs against high blood pressure in dermatology patients. Vergelijking van twee medicijnen tegen hoge bloeddruk bij dermatologie patiënten.

Ongoing
4
15
Europe
Tablet, Amlodipine, Chlortalidone
Hypertension, induced by the use of a Calcineurin Inhibitor (CNI) Hypertensie, geïnduceerd door het gebruik van een Calcineurine Remmer (CNI), Hypertension, high blood pressure Hypertensie, hoge bloeddruk, Diseases [C] - Cardiovascular Diseases [C14]
 
 
PADN-2, ChiCTR-TRC-12002097: Pulmonary Artery Denervation in Patients with Pulmonary Artery Hypertention (The trial): a randomised controlled trial

Completed
4
56
 
pulmonary artery renovation ;pharmacotherapy
Nanjing First Hospital, Nanjing Medical Hospital; Nanjing First Hospital, Nanjing Medical Hospital, Jiangsu Provincial Outstanding Medical Program
Pulmonary artery hypertension
 
 
2014-000091-25: A single-centre, placebo-controlled, double-blinded, randomized, cross-over study of Iloprost (Ventavis®) in patients with Eisenmenger syndrome

Ongoing
4
15
Europe
Ventavis, Inhalation solution, Iloprost
Royal Brompton and Harefield NHS Foundation Trust, Bayer PLC
Pulmonary Arterial Hypertension Eisenmenger syndrome, PAH Eisenmenger, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
ChiCTR-TRC-12002925: Research on the mechanisms of uric acid in development of hypertension among pre-hypertension based on metabenomic techniques

Completed
4
1500
 
No intervention ;diet intervention ;No intervention
Tianjin Medical University General Hospital; Level of the institution:, Science Foundation of Tianjin Medical University
hypertension
 
 
ChiCTR-TRC-13003690: The effection and mechanism of Fudosteine used in hypertension patients company with obstructive sleep apnea

Completed
4
120
 
patients treated with drug A(Fudosteine or placebo ;patients treated with drug A(Fudosteine or placebo)
Jiangsu Geriatric Hospital; Level of the institution:, Project of 2012 Jiangsu provincial clinical medicine technology
hypertension complicated with obstructive sleep apnea syndrome
 
 
ChiCTR-TRC-14005001: Heart Rate Variability Biofeedback Intervention on the Stress Response of Prehypertensives

Completed
4
32
 
slow abdominal breathing ;HRV-biofeedback ;Nil
Department of Physiology, Zhongshan School of Medicine, Sun Yat-sen University; Zhongshan School of Medicine, Sun Yat-sen University, This work has been supported by the Fund of Science and Technology projects in Guangdong Province (No.2010B031600075)
Prehypertension
 
 
ChiCTR-TRC-14004782: The clinical research on the influence of Bai‘ai capsule on hypertension associated with the metabolic syndrome

Recruiting
4
300
 
Basic treatment (Irbesartan 150mg each time, once a day) + Bai'ai capsules (0.5g each tablet) 3 tablets each time, 2 times a day, taking pills in the morning and 0.5-1 hours after dinner,last for 12 consecutive weeks. ;Basic treatment (Irbesartan 150mg each time, once a day) + placebo (0.5g each tablet) 3 tablets each time, 2 times a day, taking pills in the morning and 0.5-1 hours after dinner,last for 12 consecutive weeks.
Affiliated Huashan Hospital of Fudan University; Level of the institution:, Fund of Shanghai Association of Integrative Medicine
Hypertension associated with the metabolic syndrome
 
 
NCT06605326: Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective Study

Completed
4
46
NA
Subcutaneous Treprostinil
Guangzhou Institute of Respiratory Disease
Pulmonary Hypertension, Pulmonary Arterial Hypertension, Chronic Lung Disease-Associated Pulmonary Hypertension, Lung Transplantation, Heart Failure
09/24
09/24
ChiCTR-OPN-15005827: The influence of amlodipine/atorvastatin single pill therapy in patients of newly diagnosed hypertension and dyslipidemia on vascular endothelial function and endothelial microparticle

Completed
4
25
 
amlodipine/atorvastatin 5mg/10mg
Peking university third hospital cadiology department; Peking university third hospital, National Natural Science Foundation of China (No: 81300076); the Beijing Natural Science Foundation (No: 7132195); Hisun Pfizer Inc researchers sponsored funds (number: WS1931003)
hypertension and hyperlipidemia
 
 
2014-002305-38: The ALPHA Trial

Ongoing
4
72
Europe
Allopurinol, n/a, Capsule, hard
University of Dundee/ NHS Tayside
right ventricular hypertrophy associated with COPD or Interstitial Lung Disease and pulmonary hypertension, COPD or Interstitial Lung Disease with enlarged right side of heart, Diseases [C] - Cardiovascular Diseases [C14]
 
 
ChiCTR-IPR-14005491: The effect of telmisartan on the pharmacokinetics and pharmacodynamics of metformin

Recruiting
4
32
 
telmisartan
Institute of Clinical Pharmacology, Xiangya Hospitol, Central South University; Institute of Clinical Pharmacology, Central South University, 863 project
Hypertension
 
 
ChiCTR-TRC-13003155: Clinical study on hypertension and cerebral small vascular disease

Completed
4
300
 
Drug intervention
Department of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School; Department of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, self-financiing
small vessel disease
 
 
AHOCEP, ChiCTR1900021852: Efficacy of Arotinolol Hydrochloride on Major Adverse Cardiovascular Events in Hypertensive Hemodialysis Patients: An Open-label Randomized Controlled Trial

Completed
4
300
 
Routine treatment combined with arotinolol ;Routine treatment
Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; Sumitomo Pharmaceuticals (Suzhou) Co., Ltd., Sumitomo Pharmaceuticals (Suzhou) Co.,Ltd.
End-stage renal disease on maintenance hemodialysis with hypertension
 
 
ChiCTR-ONC-13004063: Early Intervention Study of Nifedipine Controlled Release Tablets on Mild Hypertension Patients with High PWV

Completed
4
120
 
Nifedipine Controlled Release Tablets
the Second Hosptial of Hebei Medical University; Bayer (China) Ltd, Secondary sponsor
Hypertension
 
 
2014-002988-16: Using Milrinone in babies with high blood pressure in the lungs soon after birth

Ongoing
4
20
Europe
Primacor 1mg/ml Solution for Injection, Solution for injection/infusion, Primacor 1mg/ml Solution for Injection
Royal College of Surgeons in Ireland, The Rotunda Hospital
Persistent Pulmonary Hypertension of the Newborn, High Blood Pressure in the Lungs of Newborn Babies, Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
 
 
ChiCTR-TRC-12002642: Upstream Therapeutic Strategies of Valsartan and Fluvastatin on Hypertension Patients with Non-chronic Atrial Fibrillation

Completed
4
2000
 
Valsartan ;fluvastatin & CCB ;valsartan & fluvastatin ;CCB
The second hospital of Tianjin Medical University; Level of the institution:, Unit self-finance, financial appropriation
Hypertension Patients with Atrial Fibrillation
 
 
ChiCTR-TRC-14004384: Long-acting Octreotide Prevents Variceal Rebleeding in Patients with Portal Hypertension

Completed
4
75
 
0.9%saline muscular injection monthly ;20mg long-acting octreotide muscular injection monthly ;40mg long-acting octreotide muscular injection monthly
Shanghai Sixth People's Hospital; Level of the institution:, self-funding
liver cirrosis, portal hypertension
 
 
ChiCTR-IIR-17010892: Long-term observation of using high Selective beta1 receptor blockeron for stable COPD combined with hypertension

Completed
4
81
 
β 1-blocker treatment ;General treatment
Sichuan Provincial People's Hospital; Sichuan Provincial People 's Hospital, no
COPD
 
 
2004-002232-26: CHANGES IN GLOMERULAR HEMODINAMICS PARAMETERS IN HIPERTENSIVE PATIENTS AFTER TREATMENT WITH LERCANIDIPINE

Ongoing
4
10
Europe
LERCANIDIPINE, ZANIDIP, ZANIDIP
HOSPITAL 12 OCTUBRE
HYPERTENSION
 
 
2004-004329-90: EARLY METABOLIC CHANGES WITH THIAZIDE OR BETA BLOCKER THERAPY FOR ESSENTIAL HYPERTENSION (MAIN STUDY).

Ongoing
4
66
Europe
ATENOLOL, BENDROFLUMETHIAZIDE, Nebivolol Hydrochloride, Amiloride hydrochloride, Hydrochlorothiazide, N/A, PL 0289/0172, Nebilet, No trade name, Apo-Hydro, Nebilet, No trade name, Apo-Hydro
CAMBRIDGE UNIVERSITY HOSPITALS FOUNDATION NHS TRUST
ESSENTIAL HYPERTENSION
 
 
2004-002020-17: ESTRATEGIAS PARA EL TRATAMIENTO DE LA HIPERTENSIÓN ARTERIAL. EVALUACIÓN DE UNA TERAPIA COMBINADA A DOSIS FIJAS (LOSARTÁN/HIDROCLOROTIAZIDA) vs MONOTERAPIA (ESTRATAAR).(STRATEGIES FOR THE TREATMENT OF ARTERIAL HYPERTENSION. ASSESSMENT OF A COMBINED THERAPY AT FIXED DOSES (LOSARTAN/HYDROCHOLOTHIAZIDE) vs MONOTHERAPY (ESTRATAAR)

Ongoing
4
140
Europe
COZAAR PLUS (losartán / hydrochlorothiazide), COZAAR PLUS, COZAAR PLUS
Catalan Society of Family Medicine, represented by Dr Mariano de la Figuera Von Wichman and Gabriel
Stage II arterial Hypertension
 
 
2005-000289-38: N-acetylcystein til gravide med præeklampsi

Ongoing
4
30
Europe
Prolonged-release tablet
Organisation name was not entered
Præeklampsi komplicerer ca. 2% af alle graviditeter og giver anledning til øget morbiditet og mortalitet for både moder og barn. Syndromet er karakteriseret ved hypertension og proteinuri og kompliceres ofte af yderligere organ-påvirkning.Symptomerne har baggrund i oxidativt stress, inflammation og endotheldysfunktion hos moderen.
 
 
2005-001004-39: Investigation of combined phosphodiesterase 5 inhibitor and isosorbide mononitrate for the treatment ofresistant hypertension

Ongoing
4
40
Europe
Viagra, Isosorbide mononitrate, Viagra, Angeze 10 Isosorbide mononitrate 10 mg Kentipine 10 Cibral tablets 10, Angeze 20 mg Isosorbide mononitrate 20 mg Cibral tablets 20 mg, Viagra, Angeze 10 Isosorbide mononitrate 10 mg Kentipine 10 Cibral tablets 10, Angeze 20 mg Isosorbide mononitrate 20 mg Cibral tablets 20 mg
University of Edinburgh
Hypertension
 
 
2005-003182-16: Blood Pressure Optimisation In Patients With Polycystic Kidney Disease And Hypertension By Rotation Through The Main Therapeutic Classes Of Antihypertensive Drugs.

Ongoing
4
42
Europe
DOXAZOSIN, BISOPROLOL, LISINOPRIL, AMLODIPINE, CANDESARTAN, BENDROFLUMETHIAZIDE, CARDURA, MONOCOR, ZESTRIL, ISTIN, AMIAS, APRINOX, CARDURA, MONOCOR, ZESTRIL, ISTIN, AMIAS, APRINOX
Addenbrooke\'s Hospital Trust
Polycystic kidney disease
 
 
2005-001551-38: A study to research if foam sclerotherapy of saphenous trunks can speed up the healing of chronic venous leg ulcers

Ongoing
4
200
Europe
Fibro-Vein, PL 0398/5000, Fibro-Vein STD Pharmaceutical Products LTD Fields Yard Plough Lane Hereford England HR4 0EL, Fibro-Vein STD Pharmaceutical Products LTD Fields Yard Plough Lane Hereford England HR4 0EL
Gloucestershire Hospitals NHS Foundation Trust
We will include patients with insufficiency of the long and/or short saphenous vein as underlying cause of their venous leg ulcer. These patients may or may not have visible varicose veins of the long and/or short saphenous vein.According to ICD classification:Chronic venous hypertension with ulcer ICD-9-CM-459.31Chronic ulcer of the skin ICD-9-CM-707
 
 
2006-000637-35: double blind crossover compariosn of diuretics in young patients with low-renin hypertension

Ongoing
4
30
Europe
Bendroflumethiazide, Amiloride, Frusemide, Spironolactone, Bendroflumethiazide, Amiloride, Frusemide, Spironolactone, Bendroflumethiazide, Amiloride, Frusemide, Spironolactone
Addenbrookes Hospital Cambridge University Hospitals NHS Foundation Trust
Low-renin hypertension
 
 
2006-000523-34: Intensiv ikke-sympatikus aktiverende vasodilaterende behandling hos patienter med mikrovaskulær angina pectoris

Ongoing
4
115
Europe
Zanidip, Diovan, Doxazosin \"Stada\", Moxonidin \"Alpharma\", Visken, Sparkal, Selo-Zok, Myonil Retard, Isodur, Centyl med kaliumchlorid, Angicor, Zanidip, Diovan, Doxazosin \"Stada\", Moxonidin \"Alpharma\", Visken, Sparkal, Selo-Zok, Myonil Retard, Isodur, Centyl med kaliumchlorid, Angicor
Århus Sygehus
Patienter med hypertension og angina pectoris og ingen signifikante stenoser ved koronararteriografi (KAG).
 
 
2006-001562-16: Studies of insulin action in patients at increased vascular risk. Modulation by antihypertensive and endocrine replacement therapy.

Ongoing
4
45
Europe
Captopril, Bendroflumethiazide, Amlodipine, Dehydroepiandrosterone, 13311/0064, 0142/0380, 17780/0216, Captopril 50mg, Bendroflumethiazide 2.5mg, Amlodipine 10mg, Captopril 50mg, Bendroflumethiazide 2.5mg, Amlodipine 10mg
Royal Group of Hospitals Trust
Protocol (a): Essential HypertensionProtocol (b): Hypertension in Type 2 DiabetesProtocol (c): Panhypopituitarism
 
 
2006-005239-32: Fosfodiesterashämmares akuta hemodynamiska effekter vid pulmonell hypertension och utvärdering av kväveoxid mätningar som icke-invasiv diagnostisk metod

Ongoing
4
50
Europe
Revatio Cialis Levitra, Revatio Cialis Levitra
Medical Sciences, Akademiska sjukhuset
 Pulmonell hypertension med kvarstående förhöjt medeltryck i arteria pulmonalis överstigande 25 mmHg i vila eller >30 mmHg under ansträngning vid hjärtkateterisering definierad av National Institute of Health (NIH). Patienten skriver på för skriftligt samtycke (Informed Consent) Patienten över 18 år
 
 
2006-005082-19: Effect of an angiotensin receptor antagonist on cerebral blood flow, cerebral perfusion pressure, and systemic and peripheral haemodynamics in patients with recent stroke.

Ongoing
4
34
Europe
Miacardis, Miacardis
Research Innovation Services, University of Nottingham
Patients who have hypertension in the context of recent stroke.
 
 
2006-005361-19: Evaluation of the efficacy of the dual endothelin 1 receptor antagonist Bosentan in the treatment of Pulmonary Hypertension secondary to Chronic Obstructive Pulmonary Disease and in the treatment of Pulmonary Hypertension secondary to sarcoidosis

Ongoing
4
45
Europe
tracleer, Tracleer, Tracleer
St Georges Hospital
Pulmonary Hypertension secondary to Chronic Obstructive Pulmonary Disease and secondary to SarcoidPatients devolop pulmonary hypertension for various reasons, two common causes are Chronic Obstructive Pulmonary disease and Sarcoid. Once developed it may go on to cause right heart failure and severe breathlessness and eventually death.We believe that the use of bosentan may lower the pulmonary hypertension and improve symptoms.
 
 
2006-003998-27: Cardiovascular and functional consquences of chronic kidney disease in older people

Ongoing
4
150
Europe
Antiadrenergic agents, peripherally acting, Low Ceiling Diuretics, Thiazides, High Ceiling Diuretics, Beta Blocking Agents, Selective Calcium Channel Blockers with mainly vascular effects, Ace Inhibitors, Plain, Angiotensin II antagonists, Plain,
Derby Hospitals NHS Foundation Trust
Chronic Kidney Disease Hypertension Falls
 
 
2006-006861-18: Comparison between beta-adrenergic blockers and angiotensin II receptor antagonists for the treatment of late hypertension in patients with repaired aortic coarctation

Ongoing
4
20
Europe
Atacand, Selokeen, Atacand, Selokeen
Department of Cardiology
Aortic coarctation and late hypertension
 
 
2006-005406-32: Doppler ultrasound investigation of microvasculature in health and disease

Ongoing
4
120
Europe
Ramipril, Bendroflumethiazide, Ramipril, Bendroflumethiazide
Belfast City Hospital Trust
Diabetes mellitusHypertension
 
 
2007-000310-36: Does statin therapy reduce sympathoexcitation in hypertension

Ongoing
4
13
Europe
Atorvastatin, lipitor, lipitor
Radboud University Medical Center Njmegen
hypertension and sympathoexcitation
 
 
2006-003473-27: Wirkung von Telmisartan 80 mg im Vergleich zu Valsartan 160 mg auf die Insulinsensitivität (HOMA) - WITEVA -

Ongoing
4
40
Europe
Diovan / Kinzal, BAY69-9291, Diovan 80/160 Kinzal 40/80, Diovan 80/160 Kinzal 40/80
MedQuality Forschung GmbH
Hypertension
 
 
2006-006981-40: Does the underlying haemodynamic abnormality determine response to antihypertensive therapy in patients with hypertension?

Ongoing
4
60
Europe
Doxazosin, Bisoprolol, Candesartan, Isosorbide mononitrate modified release, Doxazosin,
Cambridge University Hospitals NHS Foundation Trust jointly with University of Cambridge
Essential hypertension
 
 
2006-004705-26: Safety and Tolerability of Sildenafil in Patients with Eisenmenger Physiology

Ongoing
4
12
Europe
Sildenafil, Revatio ® 20 mg film-coated tablets, Revatio ® 20 mg film-coated tablets
Imperial College London
Eisenmenger Syndrome (pulmonary hypertension due to congenital heart disease)
 
 
2005-001214-40: A trial to compare the effects of nebivolol versus atenolol on various cardiovascular measurements including insulin sensitivity

Ongoing
4
50
Europe
Atenolol, Atenolol, Nebliet, Atenolol, Nebliet
Imperial College London
Hypertension
 
 
2006-006733-41: Effet de l’association fixe amlodipine/valsartan sur la Pression artérielle centrale chez des hypertendus essentiels non contrôlés par amlodipine 5mg

Ongoing
4
532
Europe
Exforge, Amlor, Atenolol, Exforge, Amlor, Atenolol
Novartis Pharma S.A.S.
Hypertension artérielle essentielle
 
 
2007-005546-20: Systemic effects of mild renal insufficiency: the relation between forearm blood flow and ADMA.

Ongoing
4
60
Europe
Rosuvastatine, Olmetec, ZD4522, Crestor, Olmetec, Crestor, Olmetec
academisch ziekenhuis Maastricht
hypertensionmild renal insufficiency
 
 
2008-000804-10: Valsartan 160 mg and hydrochlorothiazide 25 mg in subject suffering from arterial hypertension stage 1 or high normal with organ damage

Ongoing
4
20
Europe
CORIXIL, CORIXIL
UNIVERSITA, DEGLI STUDI DI NAPOLI FEDERICO II
Arterial Hypertension with organ damage
 
 
2008-001192-29: “Evaluación mediante proteómica de biomarcadores proteicos asociados con el tratamiento con Eplerenona versus espironolactona en pacientes post-infarto agudo de miocardio, diabéticos con hipertensión arterial no controlada y disfunción ventricular sistólica leve”\"Identification of proteomic biomarkers associated with eplerenone treatment versus spironolactone in post-acute coronary syndrome patients, with non-controlled arterial hypertension and ventricular dysfunction\"

Ongoing
4
24
Europe
INSPRA (eplerenona), ALDACTONE, INSPRA (eplerenona), ALDACTONE (espironolactona), INSPRA (eplerenona), ALDACTONE (espironolactona)
Fundación Investigación y Desarrollo en el Area Cardiovascular
Disfunción ventricular leve-moderada post-infarto agudo de miocardio en pacientes diabéticos con hipertensión arterial no controlada.Low-moderate ventricular dysfunction in post-acute coronary syndrome patients with diabetes and non-controlled arterial hypertension.
 
 
2008-002681-63: DOES VITAMIN D REDUCE BLOOD PRESSURE AND LV MASS IN RESISTANT HYPERTENSIVE PATIENTS WITH VITAMIN D INSUFFICIENCY?

Ongoing
4
74
Europe
Cholecalciferol, Vigantol, Vigantol
Research and Innovation Services, University of Dundee
Resistant Hypertension
 
 
2008-001509-40: Effects of beta blockers on central arterial pressure and vascular stiffness

Ongoing
4
60
Europe
Nebilet, Talliton, Betaloc Zok, Nebilet, Talliton, Betaloc Zok
Hungarian Kidney Foundation
Patients with hypertension and/or ischemic heart disease
 
 
2008-004534-24: Can high-dose vitamin D supplementation reduce blood pressure and markers of cardiovascular risk in older people with isolated systolic hypertension?

Ongoing
4
180
Europe
Cholecalciferol, Vigantol, Vigantol
University of Dundee
Isolated systolic hypertension
 
 
2008-007516-15: Comparaison des effets du nébivolol et de l\'aténolol sur la fonction endothéliale vasomotrice des artères de conductance lors de l\'hypertension artérielle essentielle

Ongoing
4
100
Europe
NEBILOX, ATENOLOL BIOGARAN 50 mg, NEBILOX, ATENOLOL BIOGARAN 50 mg
Laboratoires NEGMA
Hypertension artérielle
 
 
 

Download Options